SCHEMBL2535604

SCHEMBL2535604

CNC(=NN=O)N[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
LMNA P02545 3/20 0.34
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8581312 1.00 ALDH1A1 (0.38) ALDH1A1TP53LMNAMAPK1
SCHEMBL8710732 0.86 ALDH1A1 (0.39) ALDH1A1TP53LMNAMAPK1
SCHEMBL13496008 0.77
SCHEMBL5692486 0.77
SCHEMBL20768164 0.76 ALDH1A1 (0.35) ALDH1A1TP53LMNAMAPK1
SCHEMBL4391770 0.65 ALDH1A1 (0.35) ALDH1A1TP53LMNA
SCHEMBL1536062 0.65 ALDH1A1 (0.38) ALDH1A1TP53LMNA
SCHEMBL4646956 0.65 ALDH1A1 (0.38) ALDH1A1TP53LMNA
SCHEMBL3226475 0.64
SCHEMBL8533882 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246988-A1 BRUTON'S TYROSINE KINASE INHIBITORS OXFORD FINANCE LLC, AS COLLATERAL AGENT 2024-07-25 US disclosed
CN-112300172-B Bruton tyrosine kinase inhibitors 比奥根MA公司 2024-01-16 CN disclosed
US-20230123612-A1 Productivity and Bioproduct Formation in Phototropin Knock/Out Mutants in Microalgae TRIAD NATIONAL SECURITY, LLC 2023-04-20 US disclosed
US-20230046457-A1 BRUTON'S TYROSINE KINASE INHIBITORS BIOGEN MA INC. 2023-02-16 US disclosed
EP-3887533-B1 METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE EVONIK OPERATIONS GMBH (DE) 2023-01-04 EP disclosed
EP-3628742-B1 METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE EVONIK OPERATIONS GMBH (DE) 2022-07-20 EP disclosed
US-11198895-B2 Method for the fermentative production of L-lysine using an L-lysine excreting bacterium of the species Corynebacterium glutamicum having a completely or partly deleted WHIB4 gene EVONIK OPERATIONS GMBH (DE) 2021-12-14 US disclosed
US-20210355515-A1 METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE USING AN L-LYSINE EXCRETING BACTERIUM OF THE SPECIES CORYNEBACTERIUM GLUTAMICUM HAVING A COMPLETELY OR PARTLY DELETED WHIB4 GENE EVONIK OPERATIONS GMBH (DE) 2021-11-18 US disclosed
EP-3887533-A1 METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE USING AN L-LYSINE EXCRETING BACTERIUM OF THE SPECIES CORYNEBACTERIUM GLUTAMICUM HAVING A COMPLETELY OR PARTLY DELETED WHIB4 GENE Evonik Operations GmbH (DE) 2021-10-06 EP disclosed
CN-106191146-B Method for producing L-amino acids using bacteria of the family Enterobacteriaceae having attenuated expression of the gshA gene 味之素株式会社 2021-08-17 CN disclosed
EP-0262463-B1 NOVEL AUREOBASIDIUM SP. MICROORGANISMS, METHOD FOR PREPARING ERYTHRITOL WITH THE SAME Director of National Food Research Institute Ministry of Agriculture Forestry and Fisheries (JP) 1993-03-10 EP disclosed
US-5036011-A Biosynthesis from sugars DIRECTOR OF NATIONAL FOOD RESEARCH INSTITUTE, MINISTRY OF AGRICULTURE, FORESTRY AND FISHERIES (JP) 1991-07-30 US disclosed
US-4939091-A Biosynthesis, fermentation of sugars DIRECTOR OF NATIONAL FOOD RESEARCH INSTITUTE, MINISTRY OF AGRICULTURE, FORESTRY AND FISHERIES (JP) 1990-07-03 US disclosed
US-4654334-A ANIMAL FEEDS INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1987-03-31 US disclosed
US-4478935-A FERMENTATION NUTRIENTS TO PRODUCE POLYETHER ANTIBIOTICS, ADDING WATER SOLUBLE MANGANESE SALT TO GIVE COMPLEX INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1984-10-23 US disclosed
US-4189537-A Process of producing antibiotic BL580Δ with Streptomyces hygroscopicus AMERICAN CYANAMID COMPANY (US) 1980-02-19 US disclosed
EP-0002535-A2 Process for the preparation of 21-hydroxy-20-methyl pregnanes SCHERING AKTIENGESELLSCHAFT (DE) 1979-06-27 EP disclosed
US-4138481-A ANTICOCCIDIAL AGENTS AMERICAN CYANAMID COMPANY (US) 1979-02-06 US disclosed
US-4132779-A Antibiotic BL580 Zeta and use thereof as anticoccidial agent AMERICAN CYANAMID COMPANY (US) 1979-01-02 US disclosed
US-4066510-A ASSAY FOR MUTAGENESIS IN DIPLOID HUMAN LYMPHOBLASTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1978-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246988-A1 BRUTON'S TYROSINE KINASE INHIBITORS BTK, ABL1, SYK ALDH1A1 4783/4885TP53 1014/4885LMNA 3697/4885
US-20230046457-A1 BRUTON'S TYROSINE KINASE INHIBITORS BTK, ABL1, SYK ALDH1A1 4783/4885TP53 1014/4885LMNA 3697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.